- 当前位置:首页 > 股票大全 > 康泰生物 300601 财务分析
康泰生物财务分析
整理编辑：168股票行情网：www.gphq168.com 数据来源：互联网 经供参考
康泰生物(300601)利润表报告期 2024-03-31 2023-12-31 2023-09-30 2023-06-30 营业总收入 451,659,438.75 3,477,438,725.18 2,464,464,778.62 1,730,568,886.34 营业总成本 420,220,371.94 2,569,478,022.63 1,732,477,412.92 1,180,899,409.01 营业利润 69,940,162.05 948,916,417.9 768,749,273.17 566,356,417.92 利润总额 65,159,072.4 940,319,861.96 765,002,501.6 563,760,501.86 净利润 54,028,967.57 861,303,903.06 697,050,864.48 510,431,517.35 其他综合收益 - - - - 综合收益总额 54,028,967.57 861,303,903.06 697,050,864.48 510,431,517.35 康泰生物(300601)资产负债表报告期 2024-03-31 2023-12-31 2023-09-30 2023-06-30 流动资产合计 4,994,531,473.54 5,396,003,854.07 5,429,005,148.74 5,431,093,463.75 非流动资产合计 10,026,191,113.31 9,689,354,681.2 9,294,329,010.37 8,854,049,592.73 资产总计 15,020,722,586.85 15,085,358,535.27 14,723,334,159.11 14,285,143,056.48 流动负债合计 2,745,482,706.33 2,751,350,825.07 2,524,566,186.21 2,379,661,833.82 非流动负债合计 2,653,819,836.96 2,792,322,404.08 2,620,445,305.31 2,513,816,679.53 负债合计 5,399,302,543.29 5,543,673,229.15 5,145,011,491.52 4,893,478,513.35 归属于母公司股东权益合计 9,621,457,013.44 9,541,685,306.12 9,578,322,667.59 9,391,664,543.13 股东权益合计 9,621,420,043.56 9,541,685,306.12 9,578,322,667.59 9,391,664,543.13 负债和股东权益合计 15,020,722,586.85 15,085,358,535.27 14,723,334,159.11 14,285,143,056.48 康泰生物(300601)现金流量表报告期 2024-03-31 2023-12-31 2023-09-30 2023-06-30 经营活动现金流入小计 551,108,624.59 3,366,378,145.14 2,300,307,228.26 1,430,890,027.37 经营活动现金流出小计 627,287,484.44 2,333,275,707.82 1,674,535,201.33 1,091,639,445.6 经营活动产生的现金流量净额 -76,178,859.85 1,033,102,437.32 625,772,026.93 339,250,581.77 投资活动现金流入小计 223,100,000 1,099,584,203.08 758,358,499.81 535,038,598.7 投资活动现金流出小计 600,709,311.64 1,538,451,431.82 1,139,568,195.24 886,222,691.37 投资活动产生的现金流量净额 -377,609,311.64 -438,867,228.74 -381,209,695.43 -351,184,092.67 筹资活动现金流入小计 146,913,282.57 381,256,145.6 194,662,145 79,925,367.28 筹资活动现金流出小计 24,146,466.4 799,310,041.68 424,799,612.67 309,893,713.18 筹资活动产生的现金流量净额 122,766,816.17 -418,053,896.08 -230,137,467.67 -229,968,345.9 汇率变动对现金及现金等价物的影响 2,519.86 35,200.8 51,644.42 61,260.07 现金及现金等价物净增加额 -331,018,835.46 176,216,513.3 14,476,508.25 -241,840,596.73 期末现金及现金等价物余额 839,306,963.64 1,170,325,799.1 1,008,585,794.05 752,268,689.07
- 康泰生物300601相关数据
- 今日股市大盘指数
